IKKα loss, meanwhile, promotes the development of cutaneous, lung, and esophageal squamous cell carcinomas (SCCs) and lung and pancreatic ADCs [19,22,23,35,36,37,38,39,40], which are associated with increased NF-κB related targets and inflammation. Here, NFKB1 is linked to esophageal squamous cell carcinoma.